Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal dominant nonsyndromic deafness that has material basis in variation in the chromosome region 6p24.1-p22.3.
Features include: Inner ear hearing loss (sensorineural hearing impairment).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
RIPOR2 function has not been fully characterized.
Autosomal dominant nonsyndromic hearing loss 21 is associated with mutations in the RIPOR2 gene on chromosome 6.
Genetic testing for RIPOR2 is available. Testing is considered confirmatory for diagnosis.
No clinical trials have been registered for autosomal dominant nonsyndromic hearing loss 21.
16 publications have been identified in PubMed for autosomal dominant nonsyndromic hearing loss 21. Research spans Case Report / Case Series (33%), Basic Science / Preclinical (27%), and Epidemiology / Natural History (20%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 5 | 33% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 7:16 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Laboratory research |
4 |
27% |
Disease patterns and progression | 3 | 20% |
Research summaries | 1 | 7% |
Clinical study results | 1 | 7% |
New treatment approaches | 1 | 7% |
Hoang NC (2026). [PMID: 41955303](https://pubmed.ncbi.nlm.nih.gov/41955303/). *Hum Mol Genet*. [Epidemiology / Natural History]
Kim JA (2026). [PMID: 41619855](https://pubmed.ncbi.nlm.nih.gov/41619855/). *Mol Cells*. [Basic Science / Preclinical]
Nadar-Ponniah PT (2025). [PMID: 40094841](https://pubmed.ncbi.nlm.nih.gov/40094841/). *J Clin Med*. [Gene Therapy / Novel Therapeutics]
Seki Y (2025). [PMID: 39694491](https://pubmed.ncbi.nlm.nih.gov/39694491/). *Exp Anim*. [Basic Science / Preclinical]
Tamura M (2025). [PMID: 40937613](https://pubmed.ncbi.nlm.nih.gov/40937613/). *Neurocase*. [Case Report / Case Series]
Yuan YY (2025). [PMID: 40010783](https://pubmed.ncbi.nlm.nih.gov/40010783/). *Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi*. [Clinical Trial Publication]
Mutai H (2025). [PMID: 40295800](https://pubmed.ncbi.nlm.nih.gov/40295800/). *Sci Rep*. [Basic Science / Preclinical]
Wu KL (2025). [PMID: 40413265](https://pubmed.ncbi.nlm.nih.gov/40413265/). *Sci Rep*. [Epidemiology / Natural History]
Arif AR (2025). [PMID: 39672236](https://pubmed.ncbi.nlm.nih.gov/39672236/). *J Thromb Haemost*. [Case Report / Case Series]
Saenz Hinojosa S (2024). [PMID: 39850491](https://pubmed.ncbi.nlm.nih.gov/39850491/). *Front Genet*. [Case Report / Case Series]